Halogenated pyrimidine sensitization of low dose rate irradiation in human malignant glioma.

[1]  H. Pass,et al.  Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine. , 1992, Cancer research.

[2]  P. Gutin,et al.  Selection bias, survival, and brachytherapy for glioma. , 1992, Journal of neurosurgery.

[3]  M. Belli,et al.  The calculation of the mean inactivation dose by approximated methods. , 1991, Radiation research.

[4]  R. Tishler,et al.  Low dose rate irradiation and halogenated pyrimidine effects on human cervical carcinoma cells. , 1991, International journal of radiation oncology, biology, physics.

[5]  L. Dillehay,et al.  Response of glioblastoma cell lines to low dose rate irradiation. , 1991, International journal of radiation oncology, biology, physics.

[6]  P. Wen,et al.  Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma. , 1990, Journal of the National Cancer Institute.

[7]  R. Nath,et al.  Iododeoxyuridine radiosensitization by low- and high-energy photons for brachytherapy dose rates. , 1990, Radiation research.

[8]  L. Dillehay,et al.  A model of cell killing by low-dose-rate radiation including repair of sublethal damage, G2 block, and cell division. , 1990, Radiation research.

[9]  P. Gutin,et al.  Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. , 1989, International journal of radiation oncology, biology, physics.

[10]  S. Gebarski,et al.  Intra-arterial bromodeoxyuridine radiosensitization and radiation in treatment of malignant astrocytomas. , 1988, Journal of neurosurgery.

[11]  J. Maybaum,et al.  Analysis of bromodeoxyuridine incorporation into DNA: comparison of gas chromatographic/mass spectrometric, CsCl gradient sedimentation, and specific radioactivity methods. , 1987, Analytical biochemistry.

[12]  T. Kinsella,et al.  The use of non-hypoxic cell sensitizers in radiobiology and radiotherapy. , 1986, International journal of radiation oncology, biology, physics.

[13]  T. Kinsella,et al.  The use of halogenated thymidine analogs as clinical radiosensitizers: rationale, current status, and future prospects: non-hypoxic cell sensitizers. , 1984, International journal of radiation oncology, biology, physics.

[14]  D. Schoenfeld,et al.  Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas . A joint radiation therapy oncology group and eastern cooperative oncology group study , 1983, Cancer.

[15]  W. Shapiro,et al.  Isolation, karyotype, and clonal growth of heterogeneous subpopulations of human malignant gliomas. , 1981, Cancer research.

[16]  D P Byar,et al.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. , 1980, The New England journal of medicine.

[17]  J. Bedford,et al.  Dose-rate effects in mammalian cells in culture III. Comparison of cell killing and cell proliferation during continuous irradiation for six different cell lines. , 1979, Radiation research.

[18]  J. Bedford,et al.  Dose-rate effects in synchronous mammalian cells in culture. , 1973, Radiation research.

[19]  B. Kendall.  Book reviewAngiography of the Spinal Cord. By DjindjianR., HurthM. and HoudardR., pp. xiv + 482 (illus.), 1970, 220 F. , 1972 .

[20]  D. Awasthi,et al.  Anterior cervical vertebrectomy and interbody fusion. Technical note. , 1992, Journal of neurosurgery.

[21]  M. Prados,et al.  Stereotaxic I-125 brain implants for malignant gliomas , 1991 .

[22]  M. Grever,et al.  Radiosensitization of high grade astrocytoma utilizing IUDR in combination with stereotactic iridium-192 implantation & external beam radiotherapy , 1991 .

[23]  M. Prados,et al.  Evaluation of bromodeoxyuridine in glioblastoma multiforme: An NCCC phase II study , 1990 .

[24]  S. Leibel,et al.  Radiation therapy for neoplasms of the brain. , 1987, Journal of neurosurgery.

[25]  C. Ling,et al.  Prolonged "ultra" low-dose-rate irradiation: effects on Chinese hamster cell population growth, survival, and radiation sensitivity. , 1981, Radiation Research.

[26]  E. Hall.  Radiation dose-rate: a factor of importance in radiobiology and radiotherapy. , 1972, The British journal of radiology.